Multi-Cancer Detection Observational Cohort Study

Description

This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.

Conditions

Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.

Multi-Cancer Detection Observational Cohort Study

Multi-Cancer Detection Observational Cohort Study

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

Scottsdale

Mayo Clinic in Arizona, Scottsdale, Arizona, United States, 85259

Jacksonville

Mayo Clinic in Florida, Jacksonville, Florida, United States, 32224-9980

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Has Mayo Clinic medical record number
  • * Has undergone (within last 6 months) or scheduled to undergo a multi-cancer detection test (MCD) as ordered by provider
  • * Able to provide informed consent
  • * ≥ 21 years old
  • * Ability to provide blood sample
  • * Individuals who have situations that would limit compliance with the study requirements
  • * Institutionalized (i.e. Federal Medical Prison)
  • * Known pregnancy (self-reported)
  • * Currently undergoing active cancer treatment other than adjuvant hormone therapy
  • * Invasive cancer diagnosis within the last 3 years

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Mayo Clinic,

Jewel Samadder, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2029-06-30